Clinical Trial Update: Identification of Volatile Organic Compounds in Exhaled Air During Exacerbation of Chronic Obstructive Pulmonary Disease

View source ↗

Summary

A trial investigating volatile organic compounds in exhaled air during COPD exacerbations was terminated. The update confirms the study did not proceed further.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Chronic Obstructive Pulmonary Disease | Status: TERMINATED